PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+15.09%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.33B
AUM Growth
+$519M
(+29%)
Cap. Flow
+$284M
Cap. Flow
% of AUM
12.18%
Top 10 Holdings %
Top 10 Hldgs %
31.18%
Holding
1,170
New
202
Increased
753
Reduced
172
Closed
43
Top Buys
| 1 |
Broadcom
AVGO
|
+$15.7M |
| 2 |
Tesla
TSLA
|
+$13.8M |
| 3 |
Microsoft
MSFT
|
+$6.28M |
| 4 |
Apple
AAPL
|
+$5.88M |
| 5 |
NVIDIA
NVDA
|
+$5.68M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$4.04M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.47M |
| 3 |
eBay
EBAY
|
+$1.37M |
| 4 |
Align Technology
ALGN
|
+$1.31M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$1.3M |
Sector Composition
| 1 | Technology | 39.75% |
| 2 | Healthcare | 13.35% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Communication Services | 9.24% |
| 5 | Energy | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Centene
CNC
$15.4B
| $678K | 0.03% |
9,136
+828
| +10% | +$61.4K |
|
427
NOV
NOV
$4.85B
| $676K | 0.03% |
33,348
-6,757
| -17% | -$137K |
|
428
Equinor
EQNR
$62.9B
| $675K | 0.03% |
21,321
+4,810
| +29% | +$152K |
|
429
TAL Education Group
TAL
$6.37B
| $673K | 0.03% |
53,290
+8,642
| +19% | +$109K |
|
430
Universal Display
OLED
$6.52B
| $668K | 0.03% |
3,493
+377
| +12% | +$72.1K |
|
431
LyondellBasell Industries
LYB
$17.5B
| $668K | 0.03% |
7,022
+281
| +4% | +$26.7K |
|
432
Axsome Therapeutics
AXSM
$6.19B
| $662K | 0.03% |
8,314
+181
| +2% | +$14.4K |
|
433
Ambev
ABEV
$35.2B
| $660K | 0.03% |
235,693
+22,178
| +10% | +$62.1K |
|
434
Helmerich & Payne
HP
$2.07B
| $655K | 0.03% |
18,097
-1,637
| -8% | -$59.3K |
|
435
Arthur J. Gallagher & Co
AJG
$75.2B
| $654K | 0.03% |
2,909
+442
| +18% | +$99.4K |
|
436
Patterson-UTI
PTEN
$2.11B
| $652K | 0.03% |
60,360
+59
| +0.1% | +$637 |
|
|
INBX
437
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $651K | 0.03% |
17,124
-2,622
| -13% | -$99.6K |
|
438
Royal Caribbean
RCL
$92.8B
| $650K | 0.03% |
5,023
+292
| +6% | +$37.8K |
|
439
Vipshop
VIPS
$8.85B
| $650K | 0.03% |
36,614
+3,336
| +10% | +$59.2K |
|
440
Carrier Global
CARR
$53.2B
| $642K | 0.03% |
11,173
+1,595
| +17% | +$91.6K |
|
441
Protagonist Therapeutics
PTGX
$3.59B
| $640K | 0.03% |
27,890
-30,826
| -53% | -$707K |
|
442
Aflac
AFL
$57.3B
| $633K | 0.03% |
7,677
+1,546
| +25% | +$128K |
|
443
Bilibili
BILI
$10.2B
| $629K | 0.03% |
51,647
+12,576
| +32% | +$153K |
|
444
Diageo
DEO
$57.9B
| $628K | 0.03% |
4,308
+1,224
| +40% | +$178K |
|
445
Cemex
CX
$13.3B
| $627K | 0.03% |
80,883
+7,125
| +10% | +$55.2K |
|
446
Replimune Group
REPL
$468M
| $626K | 0.03% |
74,233
+42,676
| +135% | +$360K |
|
447
Mirum Pharmaceuticals
MIRM
$3.76B
| $625K | 0.03% |
21,170
-1,886
| -8% | -$55.7K |
|
448
Travere Therapeutics
TVTX
$2.43B
| $625K | 0.03% |
69,487
+8,504
| +14% | +$76.5K |
|
449
AngloGold Ashanti
AU
$32.6B
| $623K | 0.03% |
33,343
+1,837
| +6% | +$34.3K |
|
450
Myriad Genetics
MYGN
$642M
| $623K | 0.03% |
32,534
-6,305
| -16% | -$121K |
|